APOBEC4 - N-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-APOBEC4 - N-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | APOBEC4 - N-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | cow, dog, guinea pig, horse, human, porcine, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against APOBEC4. It was validated on Western Blot using a cell lysate as a positive control.Target Description: APOBEC4 is a putative C to U editing enzyme whose physiological substrate is not yet known.This gene encodes a member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases, which convert cytidine to uridine. Other AID/APOBEC family members are involved in mRNA editing, somatic hypermutation and recombination of immunoglobulin genes, and innate immunity to retroviral infection. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human APOBEC4 |
| Other Names | [putative C->U-editing enzyme APOBEC-4; Putative C->U-editing enzyme APOBEC-4; putative C->U-editing enzyme APOBEC-4; apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4; Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 4] |
| Gene, Accession # | [APOBEC4], Gene ID: 403314, NCBI: NP_982279, UniProt: Q8WW27 |
| Catalog # | MBS3212501 |
| Price | $335 |
| Order / More Info | APOBEC4 - N-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies